International Journal of Pharmaceutical Investigation · 2012 · 1.6K citations · 45 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryPulmonary Drug DeliveryNanocarriers For TherapeuticsNanoparticle Delivery SystemsNanoparticle FormulationsNasal Drug DeliveryNasal FormulationsPulmonary FormulationsDrug Delivery NanocarriersNanoparticle Delivery VectorsNanoparticle Drug Delivery SystemsNanoparticle Nasal FormulationsParenteral Drug AdministrationParenteral Drug Delivery SystemsPolymeric NanocarriersPulmonary Nanoparticles
Drug delivery is a method of administering pharmaceutical compounds to achieve therapeutic effects, and nasal and pulmonary routes are increasingly important alternatives to parenteral delivery, especially for peptide and protein therapeutics. The study aims to develop and evaluate drug delivery systems for nasal and pulmonary administration. The authors investigate liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins, and biodegradable polymer nanoparticles engineered for aerosol transfer, stability during aerosolization, biocompatibility, targeted lung delivery, controlled drug release, and timely degradation.
Drug delivery is the method or process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals. For the treatment of human diseases, nasal and pulmonary routes of drug delivery are gaining increasing importance. These routes provide promising alternatives to parenteral drug delivery particularly for peptide and protein therapeutics. For this purpose, several drug delivery systems have been formulated and are being investigated for nasal and pulmonary delivery. These include liposomes, proliposomes, microspheres, gels, prodrugs, cyclodextrins, among others. Nanoparticles composed of biodegradable polymers show assurance in fulfilling the stringent requirements placed on these delivery systems, such as ability to be transferred into an aerosol, stability against forces generated during aerosolization, biocompatibility, targeting of specific sites or cell populations in the lung, release of the drug in a predetermined manner, and degradation within an acceptable period of time.
45
Anjali Sharma, Sadhna Sharma, G. K. Khuller · Journal of Antimicrobial Chemotherapy · 2004 · 249 citations · Full text